eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	Retrophin,inc.
Proposed Ticker	N/A
CUSIP	761299106
Business Description	a development-stage biopharmaceutical company focused on the development,acquisition and commercialization of therapies for the treatment of serious,catastrophic or rare diseases.
Lead Underwriter	N/A
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A